Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment
AL Capatina, JR Malcolm, J Stenning… - Frontiers in Cell and …, 2024 - frontiersin.org
The events that control breast cancer progression and metastasis are complex and
intertwined. Hypoxia plays a key role both in oncogenic transformation and in fueling the …
intertwined. Hypoxia plays a key role both in oncogenic transformation and in fueling the …
Voltage-gated sodium channels, sodium transport and progression of solid tumours
JR Malcolm, N Sajjaboontawee, S Yerlikaya… - Current Topics in …, 2023 - Elsevier
Sodium (Na+) concentration in solid tumours of different origin is highly dysregulated, and
this corresponds to the aberrant expression of Na+ transporters. In particular, the α subunits …
this corresponds to the aberrant expression of Na+ transporters. In particular, the α subunits …
TARBP2 suppresses ubiquitin-proteasomal degradation of HIF-1α in breast cancer
JN Li, PS Chen, CF Chiu, YJ Lyu, C Lo… - International journal of …, 2021 - mdpi.com
TAR (HIV-1) RNA binding protein 2 (TARBP2) is an RNA-binding protein participating in
cytoplasmic microRNA processing. Emerging evidence has shown the oncogenic role of …
cytoplasmic microRNA processing. Emerging evidence has shown the oncogenic role of …
Influence of nNav1. 5 on MHC class I expression in breast cancer
AH Murtadha, IIM Azahar, NA Sharudin, ATC Has… - Journal of …, 2021 - Springer
Cancer metastasis occurs due to the ability of the tumour to evade immune recognition and
response by altering the major histocompatibility complex class I (MHC class I). A …
response by altering the major histocompatibility complex class I (MHC class I). A …
Influence of nNav1. 5 on MHC class I expression in breast cancer
MA Hafiz, AII Mohd, NA Sharudin… - Journal of …, 2021 - search.proquest.com
Cancer metastasis occurs due to the ability of the tumour to evade immune recognition and
response by altering the major histocompatibility complex class I (MHC class I). A …
response by altering the major histocompatibility complex class I (MHC class I). A …